## 5 Results Found

- FILTER BY
  - Articles
  - Videos
  - Presentation

#### ARTICLES

September 25, 2020

# Development of M0 CRPC really M0?

Objective: Highlights from “OncoTalks” Webinar conducted on 1st August 2020 on “Prostate cancer management and important updates from ASCO-20 & ASCO-GU 20” by Prof. Amit Bahl.

September 25, 2020

# Development of M0 CRPC really M0?

Objective: Highlights from “OncoTalks” Webinar conducted on 1st August 2020 on “Prostate cancer management and important updates from ASCO-20 & ASCO-GU 20” by Prof. Amit Bahl.

#### VIDEOS

Disease Classification: High Volume and High Risk disease in Prostate Cancer

# Prof. Amit Bahl highlights patient reported outcomes with Abiraterone and Docetaxel in Prostate Cancer

Disease Classification: High Volume and High Risk disease in Prostate Cancer

# Prof. Amit Bahl highlights patient reported outcomes with Abiraterone and Docetaxel in Prostate Cancer

Disease Classification: High Volume and High Risk disease in Prostate Cancer

# Prof. Amit Bahl highlights patient reported outcomes with Abiraterone and Docetaxel in Prostate Cancer

#### PRESENTATION

URO-ONCOLOGY

# Important Updates on Prostate Cancer from ASCO-20 & ASCO –GU 20

URO-ONCOLOGY

# Important Updates on Prostate Cancer from ASCO-20 & ASCO –GU 20

URO-ONCOLOGY

# Important Updates on Prostate Cancer from ASCO-20 & ASCO –GU 20

##### Do you like this? Share with your friends!